https://www.avient.com/sites/default/files/2023-03/Mevopur Healthcare Functional Additives Nucleating Application Bulletin.pdf
The additives reduce production variability, warping, and shrinking.
Copyright © 2023, Avient Corporation.
Avient makes no warranties or guarantees respecting suitability of either Avient’s products or the information for your process or end-use application.
https://www.avient.com/oasis-discharge-tips
Avient recommends that goods printed with ZFS Discharge are washed or tagged due to the presence of formaldehyde.
If mixing at the 8 percent activator-to-base ratio, the addition of more activator will not rejuvenate the base and permit the run to continue.
https://www.avient.com/knowledge-base/article/quality-design
Avient has developed the approach of “Controlled, Consistent, Compliant” for our MEVOPUR™ and REMAFIN-EP™ products, designed specifically for healthcare applications.
In addition, some specialized products are produced in internally-certified sites operating under the same ISO13485 Standard Operating Procedures (SOP).
Internal ISO13485 GMP is in operation at two additional specialist sites in Europe.
https://www.avient.com/knowledge-base/article/changing-regulations-ivdr
Mevopur™ Healthcare Functional Additives
With a broad portfolio of healthcare polymer technologies under the Mevopur™ brand, Avient can assist in addressing many of these challenges.
Mevopur™ Healthcare Functional Additives
https://www.avient.com/knowledge-base/article/quality-design?ind[]=6598
Avient has developed the approach of “Controlled, Consistent, Compliant” for our MEVOPUR™ and REMAFIN-EP™ products, designed specifically for healthcare applications.
In addition, some specialized products are produced in internally-certified sites operating under the same ISO13485 Standard Operating Procedures (SOP).
Internal ISO13485 GMP is in operation at two additional specialist sites in Europe.
https://www.avient.com/knowledge-base/article/quality-design?rtype[]=1164
Avient has developed the approach of “Controlled, Consistent, Compliant” for our MEVOPUR™ and REMAFIN-EP™ products, designed specifically for healthcare applications.
In addition, some specialized products are produced in internally-certified sites operating under the same ISO13485 Standard Operating Procedures (SOP).
Internal ISO13485 GMP is in operation at two additional specialist sites in Europe.
https://www.avient.com/center-of-excellence/avient-latin-america
Avient in Latin America
Avient Introduces ColorMatrix™ Amosorb™ Oxyloop™: A New Oxygen Scavenging Additive to Enhance Recyclability...
Q2 Avient Corporation Earnings Conference Call
More
https://www.avient.com/news/polyone-launches-dual-protection-light-barrier-clear-packaging-chinaplas-2014
Avient Announces Second Quarter 2025 Results...
Avient Announces Quarterly Dividend...
Avient To Hold Second Quarter 2025 Conference Call...
https://www.avient.com/investor-center/news/avient-announces-second-quarter-2022-results
Color, Additives and Inks
Color, Additives and Inks
Color, Additives and Inks
https://www.avient.com/sites/default/files/2024-12/2024 Avient Executive Bios_Holger Kronimus.pdf
Kronimus joined Avient in March 1999, and in addition to leading the company’s engineered materials business in Europe and India, also serves as Avient’s legal representative in the region, responsible for building and maintaining relationships with local governments and associations.
In previous roles at Avient, Mr.
Kronimus served as International Controller and Finance Director as well as other positions of financial, commercial and plant management in Avient’s Color, Additives & Ink business unit.